Table 2.
Cancer diagnosis—n. % |
All patients n. 455 |
Female n. 235 |
Male n. 220 |
|||
---|---|---|---|---|---|---|
n. | % | n. | % | n. | % | |
Non-Hodgkin lymphoma | 33 | 7.3 | 15 | 6.4 | 18 | 8.2 |
Gastric cancer | 25 | 5.5 | 9 | 3.8 | 16 | 7.1 |
Colorectal cancer | 10 | 2.2 | 4 | 1.7 | 6 | 2.7 |
Breast cancer | 10 | 2.2 | 10 | 4.3 | - | - |
Thyroid cancer | 6 | 1.3 | 3 | 1.3 | 3 | 1.3 |
Hodgkin lymphoma | 5 | 1.1 | 2 | 0.9 | 3 | 1.3 |
Large Granular Lymphocytic Leukemia | 5 | 1.1 | 3 | 1.3 | 2 | 0.9 |
Lung cancer | 4 | 0.9 | 2 | 0.9 | 2 | 0.9 |
Liver cancer | 4 | 0.9 | 2 | 0.9 | 2 | 0.9 |
Uterine cancer, body | 4 | 0.9 | 4 | 1.7 | – | – |
Uterine cancer, cervical | 3 | 0.7 | 3 | 1.3 | – | – |
Prostatic cancer | 3 | 0.7 | – | – | 3 | 1.3 |
Pancreatic cancer | 3 | 0.7 | 2 | 0.9 | 1 | 0.4 |
Other blood cancer (CML, polycythemia vera) | 3 | 0.7 | 1 | 0.4 | 2 | 0.9 |
Kaposi sarcoma | 1 | 0.2 | 0 | – | 1 | 0.4 |
Others#x0002A; | 13 | 3.5 | 7 | 3.0 | 6 | 2.7 |
Others: Bladder cancer, meningioma, melanoma, neuro-endocrine carcinoma, ocular carcinoma, kidney carcinoma, adrenal carcinoma.